Sara Miller, Staff Writer at Live Science, and Claire Maldarelli, assistant editor at Popular Science, discuss a new study that suggests that men might not be exaggerating symptoms of the flu after all...they might actually suffer more than women!
Miller and Maldarelli weigh-in on the findings, which seem to come down to estrogen. Women, because they have more of the hormone, seem to have stronger immune defenses to respiratory illness.
Both writers also talk the discrepancies in the findings. Social constructs and regular doctor visits could proect against getting sick were not taken into account in the study.
Blame geography for the U.S. getting hit by stronger, costlier, more varied and frequent extreme weather than anywhere on the planet, several experts said. But that's only part of it.
Residents across a wide swath of the U.S. raced Sunday to assess the destruction from fierce storms that spawned possibly dozens of tornadoes from the South and the Midwest into the Northeast.
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
